Denator said this week that it has named Karsten Fjärstedt vice president for global sales and marketing.
Fjärstedt joins the company from GE Healthcare Life Sciences where he has held senior management positions for the last 10 years.
Biodesy said this week that it has named Greg Yap as CEO and a director. Company founder Joshua Salafsky has been appointed as chief science officer and a director.
Yap joins the company after a stint as GE's first healthcare entrepreneur in residence. Previously he held an executive position at Ventana Medical Systems, overseeing that company's cancer assay portfolio. Prior to that post he was chief operating officer at CELLective Dx and held multiple management roles at Affymetrix, including vice president of DNA Products and vice president of molecular diagnostics.